Precise liver surgery in the treatment of metastatic liver cancer

Chen Tiantuo,Ma Jinliang,Jia Weidong
DOI: https://doi.org/10.19405/j.cnki.issn1000-1492.2013.07.032
2013-01-01
Abstract:The clinical data of 46 patents with liver metastases who were admitted to the Anhui Provincial Hospital were retrospectively analyzed.Traditional hepatectomy was performed in 27 patients(routine group) and precise hepatectomy in 19 patients(precise group).The operative blood loss,blood transfusion rate,incidence of postoperative complications,length of hospitalization,postoperative hospitalization,medical costs,one-year recurrence and survival rate were compared between the two groups of patients.Compared with the traditional hepatectomy group,the precise hepatectomy group had shorter postoperative hospitalization,lower levels of the postoperative alanine transaminase at day 1,3 and 5,lower tumor recurrence rate after one year(P < 0.05).No significant difference was found in operative blood loss,blood transfusion rate,incidence of postoperative complications,length of hospitalization,medical costs and one-year survival rate between the two groups.Precise liver surgery in the treatment of metastatic liver cancer is safer,more effective,and followed by shorter recovery time.
What problem does this paper attempt to address?